Inventor · disambiguated record
Mary Haak-Frendscho
Also filed as: HAAK-FRENDSCHO MARY
48 granted patents·8 pending applications·887 citations·filing 1994–2024
99Inventor score
Files withXOMA TECHNOLOGY LTD11PROMEGA CORP10TAKEDA PHARMACEUTICALS CO9AMGEN FREMONT INC7ASTRAZENECA AB2
Top patents by PatentIndex Score
56 records- 0198US8362211B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2011·Granted Jan 29, 2013·71 cites·12 claims
- 0298US7326414B2Antibodies to M-CSFWARNER LAMBERT CO·Filed 2006·Granted Feb 5, 2008·86 cites·66 claims
- 0397US11414496B2Anti-CD38 binding domainsMILLENNIUM PHARM INC·Filed 2020·Granted Aug 16, 2022·4 cites·21 claims
- 0497US7531166B2IL-1β binding antibodies and fragments thereofXOMA TECHNOLOGY LTD·Filed 2006·Granted May 12, 2009·49 cites·10 claims
- 0596US7744865B2IL1-β Binding antibodies and fragments thereofXOMA TECHNOLOGY LTD·Filed 2009·Granted Jun 29, 2010·23 cites·10 claims
- 0696US7582742B2Method of treating or preventing an IL-1 related disease or conditionXOMA TECHNOLOGY LTD·Filed 2008·Granted Sep 1, 2009·23 cites·12 claims
- 0796US7202343B2Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereofABGENIX INC·Filed 2003·Granted Apr 10, 2007·78 cites·39 claims
- 0895US9676869B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 13, 2017·12 cites·20 claims
- 0995US7829093B2Method of treating an IL-1 related autoimmune disease or conditionXOMA TECHNOLOGY LTD·Filed 2009·Granted Nov 9, 2010·21 cites·6 claims
- 1095US7695717B2Method of treating an IL-1 related inflammatory disease or conditionXOMA TECHNOLOGY LTD·Filed 2008·Granted Apr 13, 2010·21 cites·22 claims
- 1195US7285269B2Antibodies directed to tumor necrosis factorAMGEN FREMONT INC·Filed 2003·Granted Oct 23, 2007·101 cites·35 claims
- 1294US10494444B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 3, 2019·8 cites·10 claims
- 1394US10336833B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jul 2, 2019·9 cites·30 claims
- 1494US7932372B2Antibodies to MAdCAMAMGEN FREMONT INC·Filed 2006·Granted Apr 26, 2011·30 cites·52 claims
- 1594US7728113B2Methods of treating arthritic conditions with antibodies to M-CSFAMGEN FREMONT INC·Filed 2007·Granted Jun 1, 2010·21 cites·27 claims
- 1693US7829094B2Method of treating an IL-1 related cancerXOMA TECHNOLOGY LTD·Filed 2009·Granted Nov 9, 2010·13 cites·12 claims
- 1793US7744866B2IL-1β binding antibodies and binding fragments thereofXOMA TECHNOLOGY LTD·Filed 2009·Granted Jun 29, 2010·12 cites·10 claims
- 1893US2025171561A1Anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1992US8926969B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2012·Granted Jan 6, 2015·14 cites·17 claims
- 2092US7943121B2IL-1β binding antibodies and fragments thereofXOMA TECHNOLOGY LTD·Filed 2009·Granted May 17, 2011·11 cites·10 claims
- 2190US9790285B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 17, 2017·7 cites·24 claims
- 2290US9102744B2Conjugated anti-CD38 antibodiesELIAS KATHLEEN ANN·Filed 2011·Granted Aug 11, 2015·13 cites·17 claims
- 2390US7988968B2Method of treating an IL-1 related coronary conditionXOMA TECHNOLOGY LTD·Filed 2009·Granted Aug 2, 2011·7 cites·12 claims
- 2489US7592430B2Antibodies to M-CSFAMGEN FREMONT·Filed 2004·Granted Sep 22, 2009·22 cites·52 claims
- 2588US9206252B2Pharmaceutical compositions comprising IL-1B binding antibodies and fragments thereofXOMA TECHNOLOGY LTD·Filed 2013·Granted Dec 8, 2015·5 cites·13 claims
- 2688US8377442B2Method of treating inflammatory eye disease with IL-1β binding antibodiesXOMA TECHNOLOGY LTD·Filed 2011·Granted Feb 19, 2013·6 cites·10 claims
- 2787US7482434B2Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereofASTRAZENECA AB·Filed 2006·Granted Jan 27, 2009·8 cites·24 claims
- 2886US6008003ANon-invasive diagnostic method for interstitial cystitis and bladder cancerPROMEGA CORP·Filed 1997·Granted Dec 28, 1999·103 cites·25 claims
- 2985US12209138B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jan 28, 2025·0 cites·17 claims
- 3079US10280219B2Antibodies to M-CSFAMGEN FREMONT INC·Filed 2017·Granted May 7, 2019·1 cites·12 claims
- 3178US11434304B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 6, 2022·0 cites·28 claims
- 3278USRE45847EAntibodies to MAdCAMAMGEN FREMONT INC·Filed 2014·Granted Jan 19, 2016·2 cites·52 claims
- 3378US8188249B2Nucleic acid molecules encoding antibodies to M-CSFBEDIAN VAHE·Filed 2010·Granted May 29, 2012·2 cites·36 claims
- 3477US9328169B2Human antibodies that bind human MAdCAMPULLEN NICHOLAS·Filed 2005·Granted May 3, 2016·4 cites·39 claims
- 3576US12312411B2Anti-CD38 binding domainsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted May 27, 2025·0 cites·20 claims
- 3675US10259872B2Antibodies to MAdCAMPFIZER·Filed 2016·Granted Apr 16, 2019·1 cites·8 claims
- 3775US7687606B2Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereofASTRAZENECA AB·Filed 2006·Granted Mar 30, 2010·1 cites·33 claims
- 3875US5744319AAvian tryptase polyclonal antibody and purification method for use in human tryptase immunoassayPROMEGA CORP·Filed 1996·Granted Apr 28, 1998·21 cites·12 claims
- 3974US8101178B2Antibodies directed to tumor necrosis factor and uses thereofBABCOOK JOHN S·Filed 2007·Granted Jan 24, 2012·3 cites·21 claims
- 4073US6797461B2Tryptase substrates and assay for tryptase activity using samePROMEGA CORP·Filed 2001·Granted Sep 28, 2004·2 cites·35 claims
- 4172US5656273AMethod of treatment of parasitic infection using IgE antagonistsGENENTECH INC·Filed 1995·Granted Aug 12, 1997·31 cites·29 claims
- 4272US2020031951A1Conjugated anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 4369US2019202905A1Antibodies to m-csfAMGEN FREMONT INC·Filed 2019·Application pending·0 cites
- 4465US2019300605A1Antibodies to MAdCAMPFIZER·Filed 2019·Application pending·0 cites
- 4563US5594116ATryptase polyclonal antibody and purification method for use in human tryptase immunoassayPROMEGA CORP·Filed 1995·Granted Jan 14, 1997·12 cites·10 claims
- 4662US9718883B2Antibodies to M-CSFAMGEN FREMONT INC·Filed 2015·Granted Aug 1, 2017·0 cites·39 claims
- 4760US2012244167A1Antibodies to m-csfBEDIAN VAHE·Filed 2012·Application pending·0 cites
- 4859US6069230AHigh level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applicationsPROMEGA CORP·Filed 1994·Granted May 30, 2000·13 cites·4 claims
- 4958US2008124339A1Antibodies to MAdCAMPULLEN NICHOLAS·Filed 2007·Application pending·0 cites
- 5054US5989554AHigh level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applicationsPROMEGA CORP·Filed 1998·Granted Nov 23, 1999·10 cites·5 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →